Table of Contents Author Guidelines Submit a Manuscript

Biomarkers in Women’s Cancers, Gynecology, and Obstetrics

Call for Papers

The evolution of biomarkers in many diseases has changed diagnostic and therapeutic standards over the last decades. Especially after the publication of the reference genome about 10 years ago, many molecular methods have been developed that have led to the discovery of major pathways in the pathogenesis and the progression of many diseases. Main discoveries have been made in the field of cancer research; however, the application of novel technologies to other diseases in gynecology and obstetrics has shown advancements that are of great potential to improve clinical diagnostics, therapeutics, and patient care. Recently the implementation of new therapies together with companion diagnostics promises to identify patients that will have a specifically high response rate to the applied therapies along with rarer side effects.

We invite investigators to contribute with original research papers as well as review papers that will stimulate the understanding of biomarker use in women’s cancers, gynecology, and obstetrics. We are particularly interested in papers describing the use of biomarkers in clinical and preclinical settings. They should aim at the advancement of molecular genetics and molecular diagnostics and provide new insights into the future of biomarker use in women’s cancers, gynecology, and obstetrics. Potential topics include, but not limited to:

  • Recent developments in prediction of disease risk for healthy women
  • Advances in the use of biomarkers in the field of obstetrics
  • Latest technologies for the discovery of biomarkers
  • Role of signal transduction pathways in women’s cancers, gynecology, and obstetrics
  • Biomarkers for the prognosis and severity of diseases
  • Companion diagnostics for novel therapies
  • Recent advances in biomarker use within clinical trials

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 13 December 2013
First Round of ReviewsFriday, 7 March 2014
Publication DateFriday, 2 May 2014

Lead Guest Editor

  • Peter A. Fasching, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center EMN, Erlangen, Germany

Guest Editors

  • Gottfried E. Konecny, Department of Medicine, Division of Hematology-Oncology, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA
  • Amanda B. Spurdle, Molecular Cancer Epidemiology Laboratory, Genetics and Population Health Division, Queensland Institute of Medical Research, Royal Brisbane Hospital Post Office, Herston, QLD, Australia